C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Invests $2.28 Million in Henry Schein, Inc. (NASDAQ:HSIC)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC) in the fourth quarter, Holdings Channel.com reports. The fund acquired 32,968 shares of the company’s stock, valued at approximately $2,281,000.

A number of other institutional investors have also recently made changes to their positions in HSIC. Cromwell Holdings LLC raised its stake in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares during the last quarter. Versant Capital Management Inc lifted its position in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after acquiring an additional 335 shares during the period. Venturi Wealth Management LLC lifted its position in Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC lifted its position in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares during the period. Finally, City State Bank acquired a new stake in Henry Schein during the 4th quarter worth about $55,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on the company. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. Jefferies Financial Group lifted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. Finally, Barrington Research boosted their price objective on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. Eight equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and a consensus target price of $80.09.

Henry Schein Stock Performance

NASDAQ HSIC opened at $77.63 on Wednesday. The stock has a market capitalization of $9.68 billion, a price-to-earnings ratio of 31.95, a PEG ratio of 2.21 and a beta of 0.91. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a 50-day moving average of $74.03 and a 200 day moving average of $72.02.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.